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1. Introduction
Cytosolic calcium plays a major and central role in neuronal activity and functions both in
brain and in peripheral nervous systems, and its sustained alteration is a critical event that
leads to neuronal death. On these grounds, it is not surprising that a sustained alteration of
intracellular calcium homeostasis in neurons is a point of convergence of the cellular mecha‐
nisms underlying many neurodegenerative processes in the brain. Indeed, this has been shown
to be the case for the brain’s neurodegenerative diseases of higher incidence to humans, like
Alzheimer’s and Parkinson’s, or in the acute neurodegeneration observed in amyotrophic
lateral sclerosis, and also for major brain insults, such as excitotoxicity in trauma and ischemia-
reperfusion, inflammation and neurotoxicity by drugs and environmental chemicals.
Sustained deregulation of cytosolic calcium concentration have been reported in neuronal
apoptosis and necrosis, the two major cellular death pathways involved in brain neurodegen‐
eration. It has been experimentally demonstrated and confirmed by many investigations using
cell cultures that a sustained rise of cytosolic calcium concentration in the neuronal soma
within the range 0.5-1 μM elicits a rapid necrotic neuronal death, mediated by calcium-
dependent proteases activation, like calpains. On the other hand, long-term sustained cytosolic
calcium concentrations below 60-70 nM in the neuronal soma promote the slow development
of apoptotic neuronal death of neurons in culture [1,2]. Since the central role of calcium in
neurotransmitter secretion and neuronal plasticity is also well known, the basal steady state
cytosolic calcium concentration in the neuronal soma can be considered as a bioenergetics
marker of neuronal activity and survival. We shall then present the major calcium transport
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systems that control the cytosolic calcium homeostasis in the wider space within neurons, i.e.
in the neuronal soma. Owing to the large subcellular regionalization of neuronal processes
essential for the normal activity of neurons and especially in neuronal signal transduction
pathways, we shall also place a particular emphasis in the subcellular compartmentation of
these calcium transport systems.
Noteworthy, neurodegenerative processes in the brain also share another common metabolic
deviation,  namely,  that neurons are also exposed to an enhanced oxidative stress in the
brain. Using different types of neuronal cultures, many investigators have shown during
the last 15 years that the cellular oxidative stress produced by reactive oxygen species (ROS)
and reactive nitrogen species (RNS) and a sustained alteration of the intracellular calcium
homeostasis are metabolic deregulations usually observed during the early stages of the
development of  the process of  neuronal  death and before the cell  viability loss induced
entry in the irreversible steps characterized by the activation of proteases. In addition, it
has been proposed that alterations of the intracellular calcium homeostasis of glial cells can
also contribute to inflammation and damage in the brain in neurodegenerative processes
[3]. Therefore, a better knowledge of the major molecular pathways contributing to induce
the oxidative stress in the brain and the deregulation of intracellular calcium homeostasis
in  neurons  should be  expected to  lead to  the  development  of  novel  and more  efficient
therapies against brain neurodegeneration.
The fact that the most relevant calcium transport systems for the fine tuning of cytosolic
calcium homeostasis in neurons have been shown to be molecular targets for ROS/RNS
generated in neurodegenerative insults and diseases will be analyzed next in this context. As
most of neurotoxic ROS/RNS species react with many intracellular molecules and these species
are short-lived within the cells, the extent of chemical modification of each calcium transport
system by ROS/RNS is strongly dependent on its relative proximity to the ROS/RNS source.
In functional terms, it has been shown by many studies that ROS/RNS can elicit estimulation
or inhibition of key proteins of calcium signalling pathways in neurons, and that these effects
are strongly dependent on the specific protein, on the ROS/RNS concentration in the micro‐
environment and on the accummulated dose of ROS/RNS (time of exposure). Therefore,
clustering of these systems within subcellular microdomains plays a major role in cross-
modulation between calcium and ROS/RNS intracellular signalling, and this point will be
specifically addressed thereafter in this chapter.
Furthermore, the accummulated experimental evidences pointing out that there is an intimate
cross-talk between calcium and ROS/RNS intracellular signalling pathways are now ovel‐
whelming, including the modulation of ROS/RNS sources by calcium in neurons and the redox
modulation of calcium transport systems. Both, calcium and ROS/RNS intracellular signalling
show a clear pattern of local and focalized transients of intracellular concentration (peaks).
Therefore, clustering of calcium transport systems responsible of the rise of cytosolic calcium
and ROS/RNS sources within the same subcellular microcompartments will generate over‐
lapping focalized points of high concentration of calcium and ROS/RNS. In addition, this
clustering will produce transient and highly focalized cytosolic calcium concentration peaks
near the calcium entry points and associated calcium concentration waves owing to the rapid
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diffusion coefficient of calcium ions. Thus, we shall discuss the space and time fluctuations of
cytosolic calcium concentrations that are known to be produced by the activity of calcium
transport systems more relevant for the control of cytosolic calcium homeostasis in the
neuronal soma. Finally, the last section of this chapter is focussed in the most relevant calcium
buffering systems expressed in neurons and their modulation by oxidative stress, since calcium
buffering systems of the neuronal cytosol play a major role to attenuate the local gradients of
calcium concentration.
2. Neuronal cytosolic calcium homeostasis is attained by functional
coupling between different types of calcium transport systems
A highly efficient spatial and temporal coupling between the activity of transport systems
producing calcium entry to the cytosol and those extruding calcium out of the cytosol is a basic
bioenergetics need for brain neurons, as they establish many functional synapses and have to
maintain and rapidly restore cytosolic calcium in the neuronal soma within the narrow
concentration window that allows for neuron survival. Extensive experimental studies carried
out during last thirty years have settled the major molecular actors that allow neurons to
achieve this goal, see for example the reviews [4-7], and these are schematically presented in
the diagram of the Figure 1. Thus, the control of cytosolic calcium homeostasis in neurons is
primarily the result of the activity of transport systems at the plasma membrane acting in
concert, with the help of calcium transport systems located in intracellular stores, mainly in
the endoplasmic reticulum and mitochondria. The concentration gradient of calcium ions
across the neuronal plasma membrane in the brain is by far larger than the concentration
gradients of other ions involved in the control of neuronal excitability, like potassium, sodium
and chloride. In addition, cytosolic calcium binding proteins provide the neurons with
buffering capacity to attenuate the peak height of free cytosolic calcium concentration spikes
after focal neuronal stimulation by some neurotransmitters or after high frequency repetitive
neuronal stimulation [8].
In primary cultures of cerebellar granule neurons, calcium entry through L-type voltage-
operated calcium channel (L-VOCC) accounts for more than 75% of the increase of the steady-
state cytosolic calcium in the neuronal soma after partial depolarization of the plasma
membrane upon raising the extracellular potassium concentration from 5 to 25 mM [9]. The
particular relevance of this observation for neuronal survival is highlighted by the fact that the
apoptosis of these neurons induced by low potassium (5 mM) in the extracellular medium can
be blocked simply by raising the extracellular potassium concentration up to 25 mM [1,10].
Many other experimental data accumulated along the last two decades point out that the
transport systems more potent to elicit a fast and sustained increase of cytosolic calcium in
neurons are located at the plasma membrane, i.e. ionotropic receptors and VOCC. These
calcium transport systems are activated by extracellular stimuli, neurotransmitters or neuro‐
modulators, either directly or indirectly through plasma membrane depolarization. Let us
recall here, for example, that high frequency stimulation of neurons by application of electrical
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depolarizing pulses or of the appropriate neurotransmitter (chemical stimulation) can lead to
neuronal tetanic activity. Because of their focalized distribution pattern in the neurons and
also because of the large differences in the intensity of calcium currents across activated
ionotropic receptors and VOCC, significant calcium concentration gradients between different
cytosolic regions of the neuron during normal neuronal activity are expected to develop at
least transiently. In contrast, the rise of IP3 following activation of phospholipase C after
stimulation of members of the large family of G-coupled neurotransmitter receptors [5], also
located at the plasma membrane, promoted calcium release from intracellular stores display‐
ing calcium spikes of smaller intensity and a more widespread increase of calcium concentra‐
tion within the cytosol.
Taking into consideration the large number of different chemical molecules that promote
neuronal stimulation within the brain and the high frequency of the stimulation events, it is
Figure 1. Diagrammatic image illustrating the major calcium transport systems controlling the concentration of cyto‐
solic calcium in the neuronal soma. Yellow and white arrows indicate cytosolic calcium entry and extrusion transport
systems, respectively. The thickness of the arrow indicates the relative relevance. Abbreviations: Endopl.Ret., endoplas‐
mic reticulum (green space); NMDAr, NMDA receptor; AMPAr, AMPA receptor; L-VOCC, L-type voltage- operated calci‐
um channel; PMCA, plasma membrane calcium pump; NCX, sodium-calcium exchanger; MR, metabotropic receptor;
RyR, ryanodine receptor; IP3R, IP3 receptor; SERCA, endoplasmic reticulum calcium pump; PTP, mitochondrial permea‐
bility transition pore; CaUP, mitochondrial calcium uniporter.
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wonderful for its simplicity that the concerted action of only a few calcium transport systems
can maintain neurons functional and alive for so many years during human lifetime. Why such
a simple design? As the evolution selects the living structures and organisms that optimize the
use of metabolic energy [11] and the bioenergetics costs for building a complex structural
design is always higher than the costs for building simpler structures, probably the answer is:
to optimize the use of the metabolic energy in neurons. Let us recall here that the large needs
of metabolic energy to continuously restore the electric potential of the plasma membrane of
active brain neurons, which is essential for their proper biological functions, would not allow
them to develop a safe system for the control of cytosolic calcium homeostasis of a high-
bioenergetics cost of maintenance and repair. Noteworthy, maximal energy optimization
within the cells can be attained when the coupling between molecules involved in energy
transduction makes use of the information or entropic energy stored in subcellular structures,
i.e. minimizing stochastic collisional events that dissipate a large amount of energy, and this
seems to be the case. For example, the subcellular distribution of the calcium transport systems
in neurons enables them to use cytosolic calcium for highly polarized, rapid and specific
synaptic responses, and also for more slowly developing adaptative responses, like long term
post-synaptic potentiation or depression [4,5]. Furthermore, the different levels of expression
of ionotropic and metabotropic receptors in distinct types of neurons allows for differential
selectivity and sensitivity in calcium modulation of neuronal threshold excitability, thereby
linking regionalization of neuronal responses within the brain structures with the major
neurotransmitter pathways.
2.1. The calcium entry systems of the neuronal plasma membrane
All neurons express different types of functional VOCC. On the basis of their unitary conduc‐
tance, on their rate of inactivation and their subcellular location the most relevant for neuronal
calcium homeostasis are the L-VOCC. The L-VOCC unitary conductance has been reported to
be in the range of 20-25 pS, while reported unitary conductances for N-, P/Q- and R-type range
between 10 and 20 pS, and L-VOCC inactivation kinetics is slower than that of the other VOCC
types [12-17]. In addition, L-VOCC are polarised in the neuronal soma and at the conical neck
leading to neurite extensions [18], whereas N-, P/Q and R-types of VOCC are largely enriched
in the presynaptic plasma membranes and its activation serves largely to elicit neurotrans‐
mitter release at the synapses [14,19-21]. On these grounds, taking also into consideration the
rate of kinetics inactivation of the P/Q-VOCC, these channels should afford a contribution to
the cytosolic calcium homeostasis of the neuronal soma much lower than that of L-VOCC but
higher than that of N-, R- and T-types of VOCC. Indeed, using specific channels blockers we
have experimentally assessed that the sum of the contributions of non-L-VOCC calcium
channels to the cytosolic calcium homeostasis of the neuronal soma of primary cultures of
cerebellar granule neurons in a standard Locke’s medium with 25 mM K+ is lower than 20%,
while the L-VOCC contribution is 80% or higher (unpublished results).
L-VOCC, which are expressed in all neurons, are by far the most relevant calcium channels
not only for the tuning of steady-state cytosolic calcium homeostasis in neurons (see above),
but also for the overall threshold neuronal excitability, see [22-24]. The L-VOCC family, also
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known as CaV1, has four subtypes: CaV1.1, CaV1.2, CaV1.3 and CaV1.4 [25]. CaV1.2 and CaV1.3
are expressed in neurons, cardiac and endocrine cells, while CaV1.1 and CaV1.4 are specific of
skeletal muscle and retina, respectively [26]. In brain, near 80% of L-VOCC belongs to the
CaV1.2 subtype and 10-25% to the subtype CaV1.3 [27]. It has been reported that inactivation
of the gene encoding for CaV1.2 in the hippocampus and neocortex of mouse (CaV1.2HKO)
leads to a selective loss of N-methyl-D-aspartate (NMDA) receptors-independent long-term
potentiation [28]. The activity of these calcium channels is modulated not only by the plasma
membrane potential but it is also dependent upon their phosphorylation by protein kinases.
Meanwhile the activation of different isoforms of protein kinase C (PKC) has been reported to
produce stimulation or inhibition of L-VOCC activity in different cellular types [29], the
activation of protein kinase A (PKA) and of calcium/calmodulin-dependent protein kinase II
(CaMKII) have been shown to increase the activity of L-VOCC. Moreover, both PKA and
CaMKII have been shown to form complexes with L-VOCC subunits. In brain, PKA associates
with L-VOCC subunit α1c [30]. L-VOCC subunits α1c and β2 are phosphorylated by PKA
[31-34], and this produces an increase of L-VOCC activity. It has been demonstrated that this
increase of L-VOCC activity is mediated by phosphorylation of Ser478 and Ser479 of the β-
subunit and also by phosphorylation of Ser1928 of the α1c-subunit, as their mutations led to
complete elimination of the PKA-induced increase of calcium currents catalyzed by L-VOCC
[29,35]. Regarding CaMKII, the amino acids sequence near Thr498 of the L-VOCC subunit β2a
shows a high homology with the self-inhibitory domain of the CaMKII and with the binding
domain of this kinase in the NR2B subunit of NMDA receptors [36]. Indeed, it has been shown
the co-localization within neurons of the L-VOCC (CaV1.2 type) and CaMKII [37] and also of
the L-VOCC subunit β2a with CaMKII, and this has led to the suggestion that the L-VOCC
subunit β2a can act as an associated protein of CaMKII in vivo [36]. Phosphorylation of L-VOCC
by CaMKII takes place not only in Thr498 of the β2a subunit but also in Ser1512 and Ser1570
of the α1 subunit and leads to an increase of the intensity of calcium currents through these
channels [36, 38-40]. It has been proposed that the modulation of L-VOCC by CaMKII can be
relevant to potentiate the raise of cytosolic calcium concentration in response to hormones and
growth factors [41,42]. In contrast, the excessive activation of the L-VOCC (CaV1.3 type) by
CaMKII over-stimulation has been correlated with the loss of dendritic spines in the striatum
observed after dopamine depletion in animal models of parkinsonism [43].
The most potent calcium ionotropic receptors present in the neurons of the mammalian brain
are L-glutamate receptors of the NMDA and α-amino-3-hydroxy-5-methylisoxazole-4-
propionic acid (AMPA) subtypes, except those AMPA receptors formed only with GluR2
subunits [44,45], and P2X-purinergic receptors [46]. NMDA and AMPA receptors are present
in most fast excitatory synapses in the brain, allowing for neuronal responses in the millisec‐
onds time scale range, and P2X-purinergic receptors display also a widespread distribution in
the brain. The more limited distribution in brain of L-glutamate receptors of the kainate
subtype, its low ionic selectivity for calcium and the slight calcium currents generated upon
its activation compared to those observed upon activation of AMPA and NMDA receptors [47],
suggest that they can play at most a secondary role in the tuning of cytosolic calcium homeo‐
stasis of a very limited number of brain neurons.
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The L-glutamate receptors are expressed in the vast majority of glutamatergic neurons, and
they are present in the major structures of mammalian brain (neocortex, striatum, hippocam‐
pus and cerebellum). NMDA, AMPA and kainate receptors are oligomeric integral membrane
proteins, being their calcium channel structure predominantly formed by a combination of
different, though highly homologous, subunits [48]. Among these receptors, NMDA receptors
play an outstanding role in neurosciences, as supported by many experimental evidences in
studies of brain development [49], long term post-synaptic potentiation [4] or brain damage
after ischemia-reperfusion [44,45]. Three major reasons allows to explain the dominant role of
NMDA receptors over AMPA and kainate receptors in the brain: (1) the NMDA single channel
conductance is higher than AMPA single channel conductance, 40-50 pS versus ~20 pS [16,50];
(2) their higher affinity for the endogenous agonist L-glutamate, e.g. the EC50 for L-glutamate
is ~10 μM for NMDA receptors and ~200 μM for AMPA receptors, and (3) the slower desen‐
sitization rate of NMDA receptors, e.g. several hundreds of milliseconds for NMDA receptors
while it is ~10 milliseconds for AMPA receptors [48]. Nevertheless, the maximal activation of
NMDA receptors not only requires the presence of L-glutamate but also co-stimulation by
glycine or D-serine in the brain and relief of Mg2+ inhibition [48,51]. Both, AMPA and P2x
receptors can potentiate NMDA receptor activation in the brain. AMPA receptors co-localiza‐
tion with NMDA receptors allows that plasma membrane depolarization induced by activa‐
tion of AMPA receptors elicits the relief of Mg2+ inhibition of NMDA receptors.
Phosphorylation by PKC and CaMKII promotes synaptic incorporation of AMPA receptors
during long-term post-synaptic potentiation (LTP), and the latter kinase also enhances the
channel conductance of this receptor [52-54]. On the other hand, it has been shown that
facilitation of L-glutamate release by P2x activation can lead to a stronger NMDA receptor
activation. The calcium channel in the NMDA-receptor structure can be formed by different
combinations of subunit 1 (NR1) and one of the isoforms of subunit 2 (NR2A, NR2B, NR2C
and NR2D) [55]. The expression of functional NMDA receptors is a relatively slow process
during the maturation of neurons [56]. Therefore, in molecular terms there are different
isoforms of functional NMDA receptors whose level of expression varies from one type of
neurons to another, and also during neuronal maturation. In addition, NMDA receptors are
found in synaptic and in extra-synaptic locations [56-58]. As activation of extra-synaptic
NMDA receptors can lead to a less focalized increase of cytosolic calcium, the extra-synaptic
NMDA receptors are likely to play a role more relevant than synaptic NMDA receptors in the
control of cytosolic calcium homeostasis in the neuronal soma. Phosphorylation of NMDA
receptors in vitro by PKA and by some PKC isoforms increases their activity [59]. The co-
stimulation of PKA and PKC elicits the phosphorylation of Ser896 and Ser897 leading to
activation of NMDA receptors, while phosphorylation of Ser890 by only PKC leads to a
subcellular re-localization of the NR1 subunit of NMDA receptors, which is reverted upon
dephosphorylation [60].
2.2. Transport systems that release calcium from intracellular stores
The long-term control of neuronal calcium homeostasis also involves several major calcium
transport systems of the subcellular organelles that behave as relevant neuronal intracellular
stores, namely, endoplasmic reticulum and mitochondria.
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The endoplasmic reticulum Ca2+-ATPase (SERCA) helps to pump calcium out from the cytosol
to the endoplasmic reticulum internal space [5], while calcium release from the endoplasmic
reticulum involves the activation of IP3 receptors and/or ryanodine receptors in different
neuronal responses and in synaptic plasticity [5,61-63]. Although the neuronal endoplasmic
reticulum can accumulate much lower amounts of calcium than the sarcoplasmic reticulum of
muscle cells, it is still significant for hippocampal neurons as shown in several studies, see e.g.
[4,64]. In these cases, calcium release from the endoplasmic reticulum can sustain a moderate
increase of cytosolic calcium, which has been shown to play a significant role in the process of
LTP in hippocampal neurons [4,64]. By itself, calcium filling of the endoplasmic reticulum is
relevant for neuronal survival to ensure the correct protein folding of many proteins, partic‐
ularly proteins of the plasma membrane or to be secreted to the extracellular space, as the
activity of several endoplasmic reticulum protein-chaperones is dependent on the calcium
concentration in the internal space of the endoplasmic reticulum [65]. Depletion of calcium in
the endoplasmic reticulum has been shown to elicit the opening of specific calcium channels
of the plasma membrane, the store-operated calcium entry (SOCE) [5,66-67]. The presence of
SOCE in neurons has been documented during last years [4,68], and its opening elicits a
transient increase of cytosolic calcium under neuronal stress conditions to restore the calcium
levels of intracellular stores. The inhibition of SERCA by selective inhibitors, thapsigargin or
cyclopiazonic acid, is needed to induce the large calcium depletion in the endoplasmic
reticulum required for SOCE in experiments with cells in culture. Thus, this process can be
seen as a 'rescue call' at the cellular level and operates under conditions of severe energetic
depletion of the neurons. Indeed, it is to be recalled here that these channels and in particular
the isoforms TRPC-3 and -6 have been also involved in neuronal survival of CGN [69]. More
recently, Selvaraj et al. [70] have demonstrated that in a mouse neurotoxin-based model of
Parkinson’s disease, reduced Ca2+ influx through transient receptor potential C1 (TRPC1)
channels in the plasma membrane of dopaminergic neurons triggers a cell death-inducing
endoplasmic reticulum-stress response. These latter results highlighted for the first time the
relevance of calcium homeostasis in Parkinson’s disease.
In contrast, the large population of neuronal mitochondria can store relatively large amounts
of calcium, high enough to elicit a large increase of cytosolic calcium as shown by several
studies, see e.g. [71,72]. Nevertheless, the rate of calcium fluxes across the mitochondrial
membrane transporters in normal cells is much slower than that measured for the major
endoplasmic reticulum calcium transport systems listed above. However, calcium release from
mitochondria high enough to promote a large and sustained rise of cytosolic calcium in
neurons has been observed only during the development of neuronal cell death, as a conse‐
quence of the steady opening of the high permeability mitochondrial transition pore [73]. On
these grounds, large calcium release from mitochondria has been proposed to be part of the
molecular mechanism that triggers irreversible events in neuronal cell death through calpains
activation. On the other hand, the uptake of calcium by mitochondria takes place through a
calcium uniporter [71,73], with a rate of uptake in the submicromolar calcium range much
lower than the major cytosolic calcium extrusion pathways, namely, PMCA and SERCA in
neurons [4,6].
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2.3. The transport systems involved in calcium extrusion from the cytosol
The major plasma membrane calcium extrusion systems, PMCA and Na+/Ca2+-exchanger
(NCX) are expressed in all neuronal types. PMCA provides the major extrusion pathway
operating in neurons for the maintenance of cytosolic calcium concentrations below the
neurotoxic calcium range, i.e. <0.4 μM cytosolic calcium [6,74,75]. As PMCA is active at
cytosolic calcium concentrations below 0.4 μM [6,74], neurons must spend a significant amount
of metabolic energy (ATP) to maintain cytosolic calcium within the short concentration range
which is required for neuronal survival. Therefore, the cytosolic calcium concentration can be
considered a key bioenergetics marker of neuronal activity and survival. In contrast, NCX is
more potent than the PMCA at cytosolic calcium concentrations ≥0.5 μM [6,76]. On these
grounds, NCX can be seen as a safety system to minimise neuronal damage associated with
cytosolic calcium ≥0.4 μM, as its activation when cytosolic calcium reaches this range allows
neurons to rapidly reset cytosolic calcium to the concentration window that allows neuronal
survival, see above. The expression levels of different neuronal isoforms of PMCA undergo
significant changes during neuronal maturation [77], and a similar observation has been
reported for NCX isoforms [78]. This has been seen as a neuronal adaptative response to the
fine set of free cytosolic calcium concentration and control of cytosolic calcium homeostasis,
since it has been demonstrated that different PMCA isoforms show different affinity for
calcium [79]. On the other hand, although both PMCA and NCX are found in the plasma
membrane of the neuronal soma and neuronal dendrites, recent data cast doubt on the current
assumption that both PMCA and NCX are homogeneously distributed in the plasma mem‐
brane. For example, regulatory effects of actin cytoskeleton have been recently reported on the
NCX activity [80], and actin filaments are components of caveolin-rich structures associated
with 'lipid rafts' [81].
SERCA, which catalyzes the ATP-dependent calcium uptake by this subcellular organelle,
plays only a secondary role as a system for calcium extrusion from the cytosol because in
neurons PMCA is a calcium pump more potent than SERCA [4]. The calcium uptake by
mitochondria is performed mainly via the Ca2+ uniporter driven by the large mitochondrial
inner membrane potential [73], although the contribution of an alternate transport system yet
ill-defined in molecular terms cannot be excluded under conditions of high frequency of
cytosolic calcium peaks [82]. Nevertheless, in neurons the rate of calcium uptake by mito‐
chondria is much slower than the rate of calcium extrusion from the cytosol via the plasma
membrane systems, i.e. the PMCA and NCX, and via the SERCA.
3. Compartmentation of calcium transport systems relevant for the control
of cytosolic calcium homeostasis in nanodomains of the neuronal plasma
membrane and functional implications
Many recent experimental evidences have demonstrated that the calcium transport systems
of the neuronal plasma membrane more relevant for the control of cytosolic calcium homeo‐
stasis are clustered within focalized nanodomains of a diameter size lower or equal to few
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hundreds of nanometers. Lipid rafts of the plasma membrane are dynamic nanodomains of a
dimension between 10 and 200 nm [83], which define cellular sub-microdomains of the plasma
membrane anchoring caveolins, see e.g. [81], and it has been suggested that caveolin-rich
nanodomains associated with neuronal plasma membrane lacking the morphological appear‐
ance of “caveola invaginations” can serve to focalize signal transduction in neurons [84].
Indeed, the putative implication of lipid rafts in the regulation of intracellular calcium
homeostasis and calcium signalling pathways was already suggested in the 1970´s [85,86], but
only during the last decade this hypothesis has been experimentally demonstrated, see [87,88].
Lipid rafts are enriched in cholesterol and sphingolipids [83], including a lipid family partic‐
ularly enriched in the plasma membrane of neurons: the gangliosides [89], and define nano‐
domains of the plasma membrane for the anchoring of caveolins, flotillin, actin microfilaments
and also an increasingly higher number of palmitoylated or farnesylated proteins, see [81].
The isoform caveolin-1 binds to cholesterol and sphingolipids [90-92], and also promotes the
transport of cholesterol from the endoplasmic reticulum to the plasma membrane [93]. These
nanodomains are merging as unique platforms for intracellular signalling in neurons, as
pointed out in [84,94,95], and their stability is currently rationalized in terms of specific protein/
protein or protein/lipid interactions. Noteworthy, as caveolins can act as scaffolding proteins
in protein/protein interactions within these nanodomains [96,97], these interactions also bear
functional relevance for the protein partners and, therefore, these nanodomains cannot be
solely seen as structural elements of the plasma membrane. In this regard, it has been reported
that cholesterol depletion with methyl-β-cyclodextrin, a chemical widely used to solubilise
lipid rafts, alters the basal current of L-VOCC in foetal mouse skeletal muscle cells and
cardiomyocytes [98,99]. Also the calcium-dependent exocytosis in synaptosomes is sensible to
the cholesterol content of the plasma membrane [100], and probably one of the best docu‐
mented functions of caveolins is their implication in the maintenance of intracellular choles‐
terol homeostasis [101].
Noteworthy, using hippocampal neurons in culture it has been demonstrated the regulation
of caveolins expression by L-glutamate [102], and an increased level of caveolins expression
has been reported in Alzheimer’s disease which has been correlated with the increased level
of cellular cholesterol observed in these patients [103]. On the other hand, knockout mice in
caveolin-1 have impaired nitric oxide and calcium signalling pathways, displaying severe
vascular and pulmonary anomalies and uncontrolled cellular proliferation [104], and caveolins
mutations has been associated with muscle disorders and cancer [96]. Moreover, lipid rafts
alterations have been reported in a significant number of pathologies [105,106].
The association of the muscle type of L-VOCC with lipid rafts sub-microdomains in cardio‐
myocytes was established nearly 10 years ago [81,107]. Later, we have demonstrated L-VOCC
association with lipid rafts nanodomains in mature primary cultures of cerebellar granule
neurons using FRET microscopy imaging [108]. This association of L-VOCC with lipid rafts
nanodomains has a major functional relevance for the regulation by protein kinases of the
calcium influx through these channels in neurons. First, as noted previously in this chapter
within the brain the α1c subunit of L-VOCC forms a complex with PKA [30] and Razani et al.
[109] have demonstrated the co-localization and direct interaction between the scaffolding
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domain of caveolin-1 and the catalytic subunit of PKA in vivo and in vitro, respectively. Second,
some experimental data have suggested the possibility of direct association of CaMKII with
lipid rafts [110], which is consistent with the reported co-localization of CaV1.2, the predomi‐
nant L-VOCC subtype in the brain, and CaMKII [37]. Functional regulation of L-VOCC by
lipid rafts is also supported by the modulation of the level of phosphorylation of L-VOCC by
cholesterol depletion in cardiomyocytes [99].
Since the two major subtypes of L-VOCC present in the brain, namely CaV1.2 and CaV1.3,
directly interact with many proteins having the PDZ binding domain [111,112], proteins that
also bind to the NMDA receptor [113], the association of these receptors with lipid rafts
nanodomains is not an unexpected finding. The presence of NMDA receptors in isolated lipid
rafts has been shown by different investigators [114-117], and using fluorescence resonance
energy transfer (FRET) microscopy imaging their association with lipid rafts nanodomains in
mature primary cultures of cerebellar granule neurons has been demonstrated in a recent work
of our laboratory [117]. The critical role of proteins with PDZ domains in the association of
NMDA receptors with neuronal lipid rafts has been experimentally demonstrated using
genetically modified mice, as mutations in the NR2A and NR2B subunits which impair their
interaction with PDZ domains led to a reduction of NMDA receptors association with lipid
rafts [118]. It has been suggested that the clustering of NMDA receptors in lipid rafts-associated
sub-microdomains can potentiate the activation of these receptors, thereby serving as a
molecular mechanism for potentiation of the synaptic efficiency in neuronal connections
[116,117]. Because AMPA receptor clustering near NMDA receptors plays a key role for
NMDA receptor activation and LTP induction, it is of special neurophysiological relevance to
note here that the association of AMPA receptors with molecular components of the lipid rafts
of neuronal plasma membranes has also been experimentally demonstrated [114,119,120].
The association with lipid rafts of the major systems of the neuronal plasma membrane for
extrusion of calcium from the cytosol, PMCA and NCX, has also been experimentally assessed,
although to the best of our knowledge only in the case of PMCA this has been reported with
neuronal plasma membranes at the time this chapter was written. PMCA association with lipid
rafts has been shown using preparations of synaptic plasma membranes [121] and also in
primary cultures of rat cortical and hippocampal neurons [122]. Earlier, it was shown that the
C-terminal domain of the PMCA interacts with proteins with PDZ domains [123]. Moreover,
Jiang et al. [122] showed that disruption of lipid rafts domains by chronic depletion of choles‐
terol elicited a marked decrease of PMCA activity, suggesting that PMCA associated with lipid
rafts is more active than PMCA bound to non-raft domains. NCX has been shown to be
associated with lipid rafts in the smooth muscle of coronary arteries [124], it has also been
shown to be present in membrane fractions of vascular endothelial cells enriched in the lipid
rafts markers caveolin-1 and e-NOS [125] and the direct interaction of cardiac NCX with
caveolin-3 has been demonstrated by co-precipitation [126].
On these grounds, lipid rafts nanodomains of the neuronal plasma membrane can be seen as
microchip-like structures for the fine coupling and control of systems playing a major role in
the maintenance of a cytosolic calcium homeostasis within the range that allows for survival
and normal functionality of neurons. Because of the relevance of oxidative stress in neurode‐
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generation it is of utmost importance to note that two enzymatic sources of ROS/RNS have
been shown to be also associated with these lipid rafts nanodomains in the neuronal plasma
membrane, namely, neuronal nitric oxide synthase (nNOS) and cytochrome b5 reductase
(Cb5R). Sato et al. [127] showed that two domains of the nNOS, the oxygenase and the reductase
domains, interact with the scaffolding domain of caveolin-1. More recently, using FRET
microscopy imaging our group has shown that nNOS is associated with lipid rafts nanodo‐
mains enriched in NMDA receptors and L-VOCC in mature cultures of primary cerebellar
granule neurons [117]. Since nitric oxide play a very important role in neuromodulation, this
association bears a special relevance as protein/protein interactions regulate the enzyme
activity of nNOS as well as define anchoring points for the subcellular location of this protein
[127,128]. Indeed, it has been shown that the interaction of nNOS with caveolin-3 in skeletal
muscle modulates the catalytic activity of NOS [128]. In addition, previous works of our
laboratory have shown that the Cb5R, whose deregulation at the onset of neuronal apoptosis
generates a burst of superoxide anion that stimulates the entry in the irreversible phase
characterized by caspases activation [10,129-131], is also associated with lipid rafts nanodo‐
mains enriched in L-VOCC and NMDA receptors in mature cultures of primary cerebellar
granule neurons [108,130,131]. Moreover, the association with these lipid rafts nanodomains
of a source of nitric oxide (nNOS) and of a source of superoxide anion (Cb5R) point out that
these nanodomains may play also a major role in the focalized generation of the harmful
oxidant peroxynitrite in the plasma membrane when the neurons are exposed to sustained
cellular stress conditions. Let us recall here also that some mitochondria, a widely accepted
major ROS-producing subcellular compartment, are also close to the plasma membrane in
many neuronal types, because the cell nucleus occupies a large volume of the neuronal soma.
This protein clustering associated with lipid rafts nanodomains of the neuronal plasma
membrane is summarized in the Table 1, where proteins of the cytoskeleton typically associ‐
ated with lipid rafts are also included. Noteworthy, ROS significantly alter the actin polymer‐
isation/depolymerisation dynamics, reviewed in [132]. Because actin microfilaments are part
of the structural protein network of proteins associated with lipid rafts nanodomains, ROS are
expected to produce a significant distortion of this protein network, like nNOS which has been
shown to associate with the neuronal cytoskeleton in synaptic terminals [133]. Indeed,
regulatory effects of actin cytoskeleton have been reported on NMDA receptors activation
[134], on the distribution of L-type calcium channels in myocytes [135], and on the activity of
NCX [80].
Structural elements Calcium transport systems ROS/RNS sources Regulatory kinases
Cholesterol, Caveolins, L-VOCC, nNOS and Cb5R PKA and CaMKII
Sphingolipids, Flotillin, NMDA and AMPA receptors,
Actin microfilaments, PMCA and NCX
PDZ-binding proteins
Table 1 Molecules associated with lipid rafts in the neuronal plasma membrane of special relevance for cytosolic
calcium homeostasis and ROS/RNS-calcium signalling cross-modulation.
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In spite of the well known relevance of L-glutamate AMPA and NMDA receptors clustering
in LTP, the regulation of incorporation and dissociation of proteins in nanodomains or sub-
microdomains associated with lipid rafts is still poorly understood and, thus, it is a pending
issue. It is to be noted also that knowledge of the time scale range of the clustering dynamics
of proteins within these nanodomains is a basic need to properly understand their formation
and plasticity, and this is particularly relevant to reach firm conclusions regarding their role
as structural or adaptive elements in rapid and slow neuronal responses.
In conclusion, a close spatial location of these calcium transport proteins in the neuronal
plasma membrane can also afford a fast and fine tuning of cytosolic calcium concentrations.
Moreover, as major redox centers producing ROS are also tighly associated with lipid rafts
nanodomains, this compartmentation allows also to rationalize on simple grounds the intimate
cross-talk between ROS and calcium signalling in neurons, as well as between oxidative stress
and sustained cytosolic calcium deregulation, reviewed in [136,137].
4. Sustained alteration of cytosolic calcium homeostasis in neuronal death
Neuronal survival is extremely dependent of the fine tuning of cytosolic calcium homeosta‐
sis, because cytosolic calcium concentration has to be maintained within a relatively narrow
window for neuronal survival [1], for example, between 70 and 200 nM for cerebellar granule
neurons in culture [9,138]. An overwhelming amount of experimental data reported by many
investigators from different countries show that sustained deviations of cytosolic calcium
concentration out of this narrow window lead to neuronal cell death. Besides rapid necrotic
neuronal death induced by sustained cytosolic calcium concentration higher than 0.4 μM for
periods in the minutes time scale range [1,9,44,45,138,139], it has also been shown that apoptot‐
ic neuronal death can be induced when cytosolic calcium concentration remains very low for
longer periods of time, in the hours time scale range [1,2]. As the extracellular free calcium
concentration is approximately 1 mM, this implies that neurons need to sustain a large calcium
gradient across their plasma membranes. Owing to the large number of synaptic connections
established by neurons in the brain, these cells need to spend a large amount of metabolic energy
to maintain their cytosolic calcium homeostasis, because during synaptic activity calcium entry
is  activated through VOCC and some ionotropic  receptors,  mainly NMDA receptors.  In
addition, many neuronal processes are extremely dependent upon cytosolic calcium concentra‐
tion, such as neurotransmitter secretion and synaptic plasticity [140], neurite growth and
sprouting [141] and signalling pathways which mediate the metabolic neuronal responses to a
large number of relevant extracellular stimuli [4,5]. Therefore, the cytosolic calcium concentra‐
tion should be considered a major bioenergetic marker for neuronal activity and survival.
The increase of oxidative stress in brain is a biochemical marker associated with neurodege‐
nerative insults, like ischemia-reperfusion or inflammation, or neurodegenerative diseases of
high prevalence and relevance to humans, for example, Alzheimer’s, Parkinson’s, amyotrophic
lateral sclerosis and Huntington’s diseases. Many studies have shown that cellular oxidative
stress is caused by an imbalance between endogenous antioxidant defences and ROS produc‐
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tion in favour of the latter, which results in an excessive exposure of cells to harmful ROS/RNS.
On the other hand, it is well established now that the calcium transport systems most relevant
for the cytosolic calcium homeostasis in neurons are molecular targets for ROS/RNS and that
their chemical modification by these reactive species lead to their functional impairment.
Indeed, oxidative chemical modifications of these calcium transport systems have been
reported to take place in vivo. Moreover, many experimental studies reported during last 10
years led to the conclusion that ROS produce a sustained deregulation of cytosolic calcium
homeostasis in neurons. For example, neuronal death mediated by calpains activation can be
taken as a biological marker of a sustained rise of cytosolic calcium concentration [142-144].
Another examples are provided by the central role of L-VOCC and ROS in the apoptosis
induced by low extracellular potassium concentration [2,9,10,129,131,145], and also by L-
glutamate excitoxicity-induced neuronal death [44,45,146]. Thus, sustained alterations of
neuronal cytosolic calcium are expected to be a convergent cellular mechanism in brain
neurodegeneration. Consistent with this hypothesis, alterations of neuronal calcium homeo‐
stasis and brain oxidative stress have been reported in the case for the brain neurodegenerative
diseases of higher incidence to humans, like Alzheimer’s [147,148] and Parkinson’s [149,150],
or in the acute neurodegeneration observed in amyotrophic lateral sclerosis [146,151], and also
for major brain insults, such as excitotoxicity in trauma and ischemia-reperfusion [44,45],
inflammation [152,153] and neurotoxicity by drugs and environmental chemicals [139,154].
Most ROS/RNS that are produced in cellular oxidative stress in mammalian tissues have been
demonstrated to be strongly neurotoxic to neurons in vitro. This is a relatively large list of ROS/
RNS, and we shall concentrate in this chapter in those most studied as agents in brain neuro‐
degeneration, namely, superoxide anion, H2O2, hydroxyl radicals, lipid hydroperoxides, and
nitric oxide-derived ROS, mainly peroxynitrite and nitrogen dioxide. Because of the calcium
dependence of the activity of nNOS, the main enzymatic system responsible for the production
of nitric oxide in neurons [133], RNS should be expected to play a particularly relevant role as
intracellular biomarkers of the level of coordination or deregulation of calcium and ROS
signalling pathways in neurons. However, it is still a matter of debate whether in vivo all of
these ROS/RNS can reach concentrations high enough to act as causal agents or merely as
agents that potentiate or accelerate the rate of an ongoing neuronal death process in the brain.
Moreover, the analysis and dissection of the chemical reaction pathways of each one of this
ROS/RNS is further complicated by the fact that in vivo they generate radicalic chain chemical
reactions. Therefore, it is critical to identify the major subcellular primary sources of these ROS/
RNS in different neurons and in different degenerative processes in the brain, and this is an
issue yet to be settled in many cases, as during lasts years the experimental evidences have
pointed out that the relative relevance of different ROS/RNS seems to be largely dependent
on the neurodegenerative disease or brain insult.
5. Modulation by ROS/RNS of calcium transport systems relevant for the
control of neuronal cytosolic calcium homeostasis
ROS and RNS producing oxidative stress to neurons can be generated by neuronal and also
by non-neuronal cells, like microglia or endothelial cells of the brain blood vessels. It is to be
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noted that oxidative stress-induced brain degeneration is a relatively slow process, in most
neurodegenerative diseases developing in periods of time of years and in acute brain ischemia-
reperfusion in a time range from minutes to several days, depending upon the intensity of the
oxidative stress insult. Thus, in a brain suffering oxidative stress neurons are exposed for
relatively large time periods to either extracellularly and/or intracellularly generated ROS/
RNS. Because the extracellular liquid bathing the brain and stem neurons is poorer in antiox‐
idants than the blood, due to the low permeability and high selectivity of the blood-brain
barrier, the extracellular antioxidant protection in the brain is notably lower than that of other
organs and tissues in mammals. Under these environmental conditions the plasma membrane
of neurons, where major calcium transport systems controlling the cytosolic calcium homeo‐
stais are located, is particularly sensitive to the oxidative stress generated in the brain by vicinal
neuronal and non-neuronal cells. The major ROS/RNS reported to play a significant role in the
enhanced brain oxidative stress associated with neurodegenerative diseases and insults like
ischemia-reperfusion and inflammation can be split into three major groups: (i) primary
biochemical ROS/RNS, i.e. chemical species directly generated by some enzymes or proteins
during brain activity in normal or pathophysiological conditions, (ii) secondary biochemical
ROS/RNS, chemical species derived by rapid reaction between the primary biochemical ROS/
RNS or by systems involved in their detoxification, and (iii) radicalic chain ROS/RNS, chemical
radicals involved in the initiation of radical reaction chains or that are largely generated within
radical reaction chains.
Superoxide anion is a primary biochemical ROS that plays a key role in the generation of many
of the more harmful ROS and RNS detected in the oxidative stress-induced degeneration of
the brain. Superoxide anion can be produced by neuronal and non-neuronal cells within the
brain. Because of the relatively low permeability to superoxide anion of lipid bilayers [155],
extracellular superoxide anion must be largely generated by redox centres of the plasma
membrane of neuronal and non-neuronal cells. In glial, macrophages and endothelial cells
there are NADPH oxidases of the NOX family, which are under the control of transcriptional
antioxidant-responsive elements (ARE), reviewed in [156]. In contrast, we found that in the
plasma membrane of neurons the NADH-dependent production of superoxide anion associ‐
ated with their NADH oxidase activity was nearly ten-fold higher than their NADPH activity
[157,158]. Indeed, an overshot of superoxide anion production at the plasma membrane is an
early event in the apoptosis of cerebellar granule neurons induced by extracellular K+
deprivation [10,131], an overshot that we have found to be largely catalyzed by deregulation
of cytochrome b5 reductase associated with plasma membrane lipid rafts sub-microdomains
[130,131]. Mitochondria is now widely accepted as the major source of intracellular superoxide
anion in oxidative stress-induced neuronal death in cultures in vitro, particularly by complexes
I and III of the mitochondrial respiratory chain [159]. In addition, non-mitochondrial enzymes
that use oxygen as substrate can also become a source of intracellular superoxide anion in
neurons, such as the conversion of xanthine dehydrogenase into xanthine oxidase either by
direct oxidation and/or by proteolytic activation during oxidative stress-induced neuronal
death [160].
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Nitric oxide is the major primary biochemical RNS produced in oxidative stress-induced
brain degeneration, and although not harmful by itself, its reaction with superoxide anion
yields peroxynitrite (a secondary biochemical ROS/RNS), probably the most neurotoxic ROS/
RNS generated during oxidative stress-mediated brain neurodegeneration, see e.g. [161,162].
The reaction between nitric oxide and superoxide anion is very fast, such that it is considered
a diffusion-controlled chemical reaction due to the very high value of the bimolecular rate
constant, (4-7) 109  M-1  s-1  [163]. Peroxynitrite, in spite of its short lifetime within the cells
[162],  has  been  shown  to  be  a  very  harmful  ROS/RNS  involved  in  the  brain  damage
produced by ischemia-reperfusion [161], by inflammation and spinal cord injury [164,165]
and  also  in  neurodegenerative  diseases  and  aging  [166,167].  Peroxynitrite  can  elicit
functional  damage  of  biomolecules  and  subcellular  structures  acting  either  as  a  potent
oxidant (E0' = 1.2-1.4 V) or through the generation of harmful radicals such as hydroxyl and
nitrogen dioxide free radicals, reviewed in [162,168]. Due to this, peroxynitrite can produce
oxidation  of  protein  cysteines  to  disulfide  bonds,  sulfenic  and  sulfinic  acids  eventually
leading to sulfonic acids,  oxidation of protein methionines,  nitration of protein tyrosines
and  lipids,  lipid  peroxidation,  coenzyme  Q  oxidation,  and  DNA  and  RNA  oxidation.
Because the activation of neuronal nitric oxide synthase requires an increase of cytosolic
calcium, peroxynitrite is one of the more harmful ROS/RNS produced in the oxidative stress
accompanied by sustained alterations of the neuronal cytosolic calcium homeostasis. Indeed,
this  has  been  shown  to  be  the  case  for  the  excitotoxic  neuronal  death  elicited  by  L-
glutamate through activation of NMDA receptors [166,169].
ROS/RNS initiating lipid oxidation and peroxidation, i.e. self-accelerating chemical radical
chains, are the other group of ROS/RNS playing a major role in brain damage by oxidative
stress. Among them, H2O2 has required a large attention because is one of the major products
generated under conditions that elicit over-production of superoxide anion, as it is a product
of superoxide dismutase activity. In addition, intracellular traces of metal ions such as Fe3+ or
Cu2+ can catalyse Fenton-like reactions in neurons, generating hydroxyl radical from super‐
oxide and H2O2 [170]. Hydroxyl radical is one of the most potent cytotoxic oxygen radicals,
which can attack a large variety of important biomolecules, from small biomolecules such as
coenzyme Q or α-tocopherol [171] up to large biomolecules like proteins, RNA and DNA
[170,172]. Since hydroxyl radical can be also generated from peroxynitrite decomposition (see
above), it turns out that it is a converging point between the oxidative stress pathways
involving ROS and RNS derived from nitric oxide. The involvement of hydroxyl radical in
oxidative stress-induced neuronal damage has been suggested, for example, in the pathophy‐
siological case of spinal cord trauma [173], amyotrophic lateral sclerosis [174] and Parkinson's
disease [170,175].
Lipid ROS are a family of harmful ROS detected in oxidative stress-mediated brain degener‐
ation that also catalyze chemical radical reaction chains. They can be produced as primary
biochemical ROS by cyclooxygenases (COX) and lipoxygenases in some brain oxidative stress
insults, such as ischemia-reperfusion [176], or Parkinson's disease [177]. Indeed, inhibitors of
the neuronal COX-2 isoform have been reported to attenuate brain damage after ischemia-
reperfusion [176]. Moreover, the oxidation of dopamine by the microglial COX-1 isoform and
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also by COX-2 isoform in the dopaminergic neurons of the substantia nigra has been involved
in the pathogenesis of Parkinson's disease [177]. It is to be noted though that lipid ROS are also
generated during hydroxyl radical- and hydrogen peroxide-induced lipid oxidation and
peroxidation, respectively [170]. In addition, lipid oxidation and peroxidation also release the
aldehydes malondialdehyde and 4-hydroxynonenal, which have been shown to be highly
neurotoxic compounds [178,179]. Because of the self-propagating properties of lipid radical
chains once they are initiated, and also due to the high toxicity for neurons of lipid breakdown
compounds released, the possibility of cell rescue after the threshold antioxidant barrier
against lipid oxidation/peroxidation is surpassed can be considered negligible. The extent of
lipid oxidation marking the 'point of no return' for neurons survival has not been firmly
established yet, but it is likely to be at most only a few per cent of the total lipids [180]. On
these grounds, an enhanced lipid oxidation should be expected to be a late and largely
irreversible step in neuronal death. This view is consistent with the many reports showing that
largely damaged brain areas after an ischemia-reperfusion insult display a marked increase of
lipid peroxidation.
5.1. Modulation by ROS/RNS of the major calcium entry systems of the neuronal plasma
membrane
5.1.1. Voltage-operated calcium channels
As indicated above in the section 2 of this chapter, the L-type are the most relevant VOCC in
the fine tuning of the steady state level of cytosolic calcium concentration in the neuronal soma
and, thus, in the fine tuning of threshold neuronal excitability [22-24]. L-type VOCC as a
primary target for ROS in brain is also supported by the hypoxic up-regulation of these
channels, which is mediated by Alzheimer's amyloid peptides [181]. L-VOCC contain two
vicinal cysteines at positions 271 and 272 which are involved in their interaction with syntaxin
1A, thereby playing a major role in their regional localization in plasma membrane microdo‐
mains [182]. In addition, three cysteines are located in the calcium-pore region (Cys330,
Cys1383 and Cys1396) [183]. Therefore, L-VOCC contains redox centres that have been shown to
react with ROS/RNS in other proteins, for example, in NMDA-receptors (see below).
Studies with neurons in culture have provided ample experimental evidences of direct
modulation of L-VOCC by the major ROS/RNS involved in brain ischemia-reperfusion,
inflammation and/or neurodegeneration. The L-VOCC antagonist nifedipine has been
reported to protect CNS neurons against hydrogen peroxide-induced death, which is mediated
by a sustained increase of cytosolic calcium, pointing out activation of L-type VOCC by H2O2
[184]. H2O2 was shown later to activate recombinant calcium channel α1C subunit stably
expressed in HEK 293 cells [185]. In addition, nitric oxide has been reported to induce activation
of L-VOCC in hippocampal neurons by plasma membrane depolarization [186] or to inhibit
calcium channel gating via activation of cGMP-dependent protein kinases [187]. In contrast,
exposure to peroxynitrite has been reported to produce decrease of calcium influx through L-
VOCC at low submicromolar doses in rat cerebellar granule neurons in culture and increase
of calcium influx through L-VOCC at higher micromolar doses in rat cerebellar granule
Cytosolic Calcium Homeostasis in Neurons — Control Systems, Modulation by Reactive Oxygen and…
http://dx.doi.org/10.5772/57576
75
neurons in culture [9] and in mouse cerebral cortical neurons [188]. Hydroxyl radicals, a radical
produced during the decomposition of peroxynitrite, have been reported to suppress the
calcium influx through L-VOCC in mouse cortical neurons [189]. Consistent with these results,
dihydropyridine L-VOCC blockers afford protection against neuronal death induced by
exposure of neurons in vitro to the peroxynitrite-releasing agent SIN-1 [9,190]. Because of the
short lifetime and high reactivity of these radicals this is likely to be due to direct chemical
modification of L-VOCC, although it is to be noted that this chemical modification is yet
unknown. In addition, it has been reported that eicosanoids and ROS generated during
arachidonic acid oxidative metabolism also activate L-VOCC [191], and that the lipid peroxi‐
dation product 4-hydroxynonenal causes opening of the L-VOCC, resulting in an increase of
cytosolic calcium and neuronal death which is prevented by the L-VOCC blocker nimodipine
[192]. Direct redox modulation of L-VOCC is further supported by its activation by hydrogen
sulphide [138]. Further studies are needed to reach firm conclusions regarding the molecular
mechanisms of modulation of different neuronal L-VOCC subtypes by ROS.
Only very scarce experimental studies have been done on the putative modulation of N-,
P/Q- and R-type VOCC by ROS/RNS, despite the fact that N- and R-type of calcium channels
are blocked by heavy metals such as Pb2+ and Hg2+ that are likely to interact with thiols [193].
CaV2.2 (N-type) channel gating is inhibited by nitric oxide via cGMP-dependent protein kinase,
as it is also the CaV1 (L-type) channel [187]. Also, the lipid peroxidation product 4-hydroxy‐
nonenal increased the calcium influx through L-type and other ill-defined types of VOCC [178].
5.1.2. NMDA and other ionotropic receptors with calcium channel activity
It is well known the relevant role of NMDA-receptor mediated excitotoxic neuronal death in
ischemia-reperfusion brain injury, see [44,45], in multiple chemical sensitivity in brain [194],
in neuronal glutathione depletion [195] and in hydrogen sulfide-induced neuronal death
[138,196]. Therefore, it is not surprising that the redox modulation of the NMDA-receptor is
by far the most studied within the group of ionotropic receptors. The redox modulatory site
of the NMDA-receptor consists of thiols groups that are vicinal in the three-dimensional
structure and may form disulfide bonds under the cellular oxidative stress conditions induced
by ROS [197], and it acts as a gain control for current flux through the NMDA-receptor
[197,198]. Moreover, a significant number of NMDA-receptor cysteines are in the domains of
this receptor facing the extracellular space, including at least one pair of vicinal thiols [199].
Thus, this receptor can also play a major role in the rapid neuronal adaptation to changes of
the redox potential in the extracellular fluids within the brain, and the different types of
NMDA-receptors display a redox response that is dependent on the type of NR2 forming the
channels [55]. The differential redox-sensitivity of NMDA receptors isoforms led to the
discovery of two redox modulatory centres within the NMDA-receptor structure, one formed
by Cys744 and Cys798 on the subunit NR1 and a second one on the subunit NR2A [200,201].
Whereas the redox centre of the subunit NR1 plays a major role in the redox modulation of
NR1/NR2C- and NR1/NR2B-containing receptors, the redox centre of subunit NR2A is
sufficient for the expression of redox sensitivity in NR1/NR2A-containing receptors [201].
Redox active compounds modulate NMDA-receptors such that reduction of NMDA-receptor
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increases NMDA-receptor activity and their oxidation leads to a decrease of NMDA-receptor
activity [202].
Because of the high physiological relevance of nitric oxide and of NMDA receptors in the brain,
the modulation of NMDA receptors by nitric oxide is of particular relevance. Nitric oxide
inhibition of NMDA-receptor response in cortical neurons in culture has been rationalized in
terms of NO-induced disulfide bonds between vicinal thiols of the NMDA-receptor, and was
proposed to afford neuronal protection against L-glutamate excitotoxicity [203]. Indeed, it has
also been reported that thiol-reducing agents such as dithiothreitol increase the open dwell-
time and opening frequency of NR1/NR2A channels [55,201]. Consistent with these findings,
it has been reported that the novel neuromodulator hydrogen sulphide potentiates NMDA-
receptor response in hippocampal neurons [204] and in cerebellar granule neurons [138], and
that over-stimulation of NMDA-receptors by hydrogen sulphide can lead to excitotoxic
neuronal death [138,196]. Glutamate-induced excitotoxic neuronal death has been shown to
mediate brain injury after a transient focal cerebral ischemia episode [44,45]. Inhibitors of the
H2S-producing enzymes cystathionine β-synthase and cystathionine γ-lyase reduced the
infarct volume in a dose-dependent manner, while administration of sodium hydrosulfide
significantly increased the infarct volume after a transient focal cerebral ischemia insult [205].
Exposure of neurons to peroxynitrite also leads to activation of calcium entry through NMDA-
receptors [166,169]. This effect of peroxynitrite has been rationalized in terms of the rise of L-
glutamate concentration within the synaptic cleft, either due to potentiation by nitric oxide
and/or peroxynitrite of L-glutamate secretion in synaptic terminals [194,206] or of inhibition
of L-glutamate transporters catalyzing its re-uptake [207].
Besides the major role of NMDA-receptors on the neuronal damage elicited by ROS and/or
oxidative stress, AMPA receptors have been also involved in the neurotoxicity of ROS. It has
been reported that the increase of cytosolic calcium associated with the influx of Ca2+ through
the ionotropic AMPA-receptors can stimulate nNOS leading to an enhanced production of
nitric oxide within L-glutamatergic neurons [208]. Moreover, antagonists of AMPA/kainate-
receptors have been reported to prevent the loss of cell viability induced by the peroxynitrite-
releasing agent SIN-1 in mixed cortical cell cultures containing both neurons and astrocytes
[209]. AMPA-receptors contain a disulfide bond between cysteines 260 and 315 in the ligand
binding domain of receptor subunit GluRD, which has been proposed to act as a redox centre
implicated in direct redox modulation of these receptors [210]. Nevertheless, the redox
modulation of AMPA-receptors is a topic that will require further studies to develop an
integrative view of its modulation by the different ROS that has been implicated in brain
damage.
Finally, the response of the purinergic ionotropic P2X-receptors has been shown to be altered
by acute hypoxia, an effect that has been proposed to be mediated by ROS because H2O2
attenuated the effect of hypoxia on homomeric P2X2 whole-cell currents, which are reversibly
reduced to 38% of control by H2O2 [211]. Yet, studies regarding the putative modulation of
P2X-receptors by other ROS are a pending issue.
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5.2. Modulation by ROS/RNS of the transport systems that release calcium from
intracellular stores
5.2.1. Endoplasmic reticulum
ROS/RNS have been shown to elicit a potent stimulation of calcium release from the endo‐
plasmic reticulum, through activation of IP3 and ryanodine receptors.
Superoxide anion and H2O2 have been reported to induce calcium release from the endoplas‐
mic reticulum of neurons through activation of IP3 receptors [212,213]. Oxidized glutathione
and the alkyl mercury compound thimerosal, a thiol specific agent, increase the affinity of
IP3 receptors for IP3, thereby sensitizing this receptor to basal IP3 level in the cell and promoting
calcium release from the endoplasmic reticulum to the cytosol [214,215]. Cysteine clusters
highly reactive against ROS have been recently identified in the IP3 receptors [216]. IP3
receptors are inhibited by interaction with luminal endoplasmic reticulum proteins through
luminal-facing domains of the receptor containing reduced cysteines, and oxidation of these
cysteines weakens these interactions leading to IP3 receptor activation [63,217]. Moreover,
nitric oxide-induced increase of IP3 binding to the IP3 receptor in hypoxic brain has been
proposed to mediate IP3 receptors activation in calcium-dependent neuronal apoptotic death
induced by hypoxia [218].
Although all ryanodine receptor isoforms are expressed in the brain, the isoform 2 is the most
heavily expressed [219, 220]. Many studies have addressed the redox modulation of the
ryanodine receptors in myocytes and in neurons, reviewed in [62,64,221]. Nitric oxide activates
the skeletal and cardiac ryanodine receptors [222,223]. The activation of the ryanodine receptor
by nitric oxide has been shown to be due to the presence of highly reactive cysteines of the
receptor, which are S-nitrosylated upon exposure to nitric oxide [222-224]. The cysteines that
are S-nitrosylated upon in vitro exposure to nitric oxide have been identified [225]. However,
in vivo the extent of S-nitrosylation of ryanodine receptor cysteines is highly modulated by the
physiological oxygen tension, leading to the concept that ryanodine receptors can operate as
a coupled redox sensor for oxygen and nitric oxide [226,227]. In vitro studies have shown that
these cysteines of the ryanodine receptor are highly sensitive to oxidative stress and are likely
to mediate the redox ryanodine receptor response to another ROS, as they are also prone to
reversible S-glutathionylation or oxidation to disulfide bonds [225]. The ryanodine receptors
are also activated by hydroxyl radical, H2O2, the disulfide bond-forming agent diamide and
also by oxidized glutathione [221,224,228]. Overall, oxidizing conditions favor the opening of
the ryanodine receptor calcium channel, and on these grounds it has been proposed that
activation of these calcium channels are also involved in the pathology of brain ischemia-
reperfusion [229] and Alzheimer´s disease [230]. Noteworthy, a moderate and sustained
stimulation of the ryanodine receptors in the hippocampus has been involved in the sustained
increase of cytosolic calcium needed for the induction of the long-term postsynaptic potentia‐
tion associated with memory formation [231,232].
Calcium accumulation within the luminal space of the endoplasmic reticulum is performed
by Ca2+-ATPases (SERCA), whose activity is inhibited by exposure to H2O2, superoxide anion
and peroxynitrite [233-236], the major ROS produced in brain insults such as ischemia-
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reperfusion or inflammation and in neurodegeneration. Despite that the isoforms of SERCA
most sensitive to ROS, i.e. SERCA2 isoforms, are expressed in brain, the relevance of the
impairment of their activity to alterations of neuronal cytosolic calcium homeostasis has yet
to be conclusively demonstrated, probably because in neurons the PMCA is a calcium pump
more potent than SERCA for calcium extrusion from the cytosol.
The  apparently  higher  susceptibility  to  ROS/RNS of  the  calcium release  systems  of  the
endoplasmic  reticulum,  ryanodine and IP3  receptors,  should lead under  oxidative  stress
conditions to at least a partial depletion of the calcium concentration within the luminal
space of this subcellular compartment, see for example [237]. It should be noted, though,
that  in  neurons  the  amount  of  calcium  stored  in  the  endoplasmic  reticulum  is  small
compared with the amount of calcium entering through plasma membrane calcium channels
and ionotropic receptors. However, in most severe cases the depletion of calcium can elicit
the  opening of  plasma membrane SOCE,  see  section 2.2  of  this  chapter.  Thus,  the  rele‐
vance of calcium release from the endoplasmic reticulum or of inhibition of the SERCA to
the observed alterations by ROS/RNS of cytosolic calcium homeostasis will strongly depend
on the differential expression of SOCE isoforms in different type of neurons. On the other
hand, the depletion of calcium of the endoplasmic reticulum may lead to a dysfunctional
endoplasmic  reticulum  by  itself,  because  of  the  relevance  of  the  endoplasmic  calcium
concentration for the correct folding and processing of membrane and secretory proteins
[65, 238]. On these grounds, these authors have proposed that ROS/RNS-induced endoplas‐
mic reticulum dysfunction can be a mechanism underlying slow-developing cell injury in
ischemia-reperfusion,  epileptic  seizures  and  degenerative  diseases  of  the  brain  like
Alzheimer's and Parkinson's diseases. In addition, it has been recently shown that muta‐
tions in presenilin-1 and -2 observed in nearly 40% of familial Alzheimer's disease lead to
calcium  release  from  the  endoplasmic  reticulum  [239].  Moreover,  presenilins  by  them‐
selves can form calcium leak channels in the endoplasmic reticulum whose properties are
altered in mutant presenilins linked to Alzheimer's disease [240].
5.2.2. Mitochondria
A key role has been proposed for mitochondrial dysfunctions in the onset or development of
neuronal death in the brain mediated by the enhanced oxidative stress observed in relevant
neurodegenerative disorders, such as Alzheimer's and Parkinson's diseases, amyotrophic
lateral sclerosis and Friedreich's ataxia, and in harmful brain insults like ischemia-reperfusion
and glutamate excitotoxicity, reviewed in [166,241,242]. Mitochondrial calcium overload is
observed in excitotoxic conditions that produce a sustained increase of neuronal cytosolic
calcium or high frequency repetitive cytosolic calcium peaks [73]. ROS/RNS have been shown
to promote opening of the permeability transition pore of mitochondria and this effect of ROS/
RNS is enhanced by mitochondrial calcium overload [71,73,166]. Opening of the permeability
transition pore leads to a significant calcium release from mitochondria which contributes to
foster excitotoxic neuronal death [71, 243], and also is an important factor in necrotic cell death
following ischemia-reperfusion [73] or in neurons exposed to transient hypoglycemia [244].
Consistently, calcium-dependent mitochondrial dysfunction by peroxynitrite has been
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demonstrated to elicit necrotic cell death via activation of calpains [245]. In addition, opening
of this pore has also been shown to mediate the neuronal apoptosis elicited by 3-nitropropionic
acid, an agent which has been used to mimic in model rodents the brain neurodegeneration
observed in Huntington's disease [246]. Despite that most of studies concerning ROS-stimu‐
lated release of calcium from mitochondria point out a major role of the permeability transition
pore, it should be recalled that the inner membrane Na+/Ca2+-exchanger, i.e. the other major
mitochondrial calcium release system [71], is also sensitive to oxidative stress. It has been
reported that oxidative stress mediated by H2O2 modulates this exchanger and can lead to
activation of caspase 3-dependent apoptosis due to mitochondrial Na+ overload [247].
The permeability transition pore opening induced by ROS/RNS is mediated by oxidation of
critical thiols of proteins forming the pore, as it can be elicited by a relatively large number of
oxidizing agents such as diamide, dithiopyridine, singlet oxygen, diazoxide, nitric oxide, S-
nitrosothiols and selenium [221]. The adenine nucleotide transporter of the inner mitochon‐
drial membrane and the voltage-dependent anion channel of the outer mitochondrial
membrane have been proposed to be part of the molecular structure of the permeability
transition pore, and both proteins have shown to be modulated by oxidative stress and
exposure of mitochondria to chemically defined ROS, such that oxidation of thiols of the
adenine nucleotide transporter facing to the mitochondrial matrix have been shown to elicit
the opening of the permeability transition pore, reviewed in [73].
5.3. Modulation by ROS/RNS of the transport systems involved in calcium extrusion from
the cytosol
Much of the interest on modulation of PMCA and Na+/Ca2+-exchanger of neurons by ROS is
based on the reported decrease of these activities in synaptic plasma membranes in aging, and
the possibility that this could lead to a sustained increase of the steady state cytosolic calcium
in aged animals with respect to young animals [248,249].
5.3.1. PMCA
It has been shown that incubation of brain synaptic plasma membranes with Fe2+/EDTA,
H2O2, peroxyl radicals generated by azo-initiators and peroxynitrite resulted in a significant
loss of PMCA activity [250-253]. Inhibition of purified PMCA by H2O2 has been proposed to
be due to oxidation of two cysteines of this protein [253]. Also, lipid peroxidation and the lipid
peroxidation product 4-hydroxynonenal have been shown to inhibit the PMCA actvity [254].
In the case of incubation with peroxynitrite, the loss of Ca2+-ATPase activity was paralleled by
decrease of ATP-dependent calcium uptake activity and by a significant increase of tyrosine
nitration of the PMCA [252]. However, it is to be noted that all these studies were carried out
in vitro with purified plasma membranes in an altered environment with respect to the normal
redox cytosolic environment in living neurons, and this has to be taken into account since
endogenous antioxidant levels of reduced glutathione has been shown to largely attenuate the
inhibition of PMCA by peroxynitrite [252]. In addition, the concentrations of H2O2 and
peroxynitrite producing approximately 50% inhibition of the PMCA in these studies, higher
than 100 μM in both cases, were much higher than those reported to be attained in brain after
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transient focal ischemia or inflammation. For the case of neuronal exposure to peroxynitrite
fluxes mimicking those attained in inflammation or ischemia-reperfusion, in a previous work
of our laboratory it was shown that in cerebellar granule neurons in culture the PMCA is
significantly inhibited in less than 2 hours exposure to micromolar concentrations of peroxy‐
nitrite, although it was also noted that the PMCA has nearly ten-fold lower sensitivity to
peroxynitrite than L-VOCC [9].
N a + / Ca 2+− exchanger  (NCX )
The NCX has been reported to be less sensitive to inhibition by the peroxyl radical azo initiator
2,2'- azobis (2-amidinopropane) dihydrochloride (AAPH) and peroxynitrite than the PMCA
[251], and also to be insensitive to inhibition by up to 700 μM of H2O2 [255]. The Na+/Ca2+-
exchanger activity of synaptic brain plasma membranes and in transfected CHO-K1 cells has
been reported to be inhibited by exposure to AAPH and also to peroxynitrite [255], although
it must be noted that peroxynitrite only afforded a partial inhibition of the exchanger caused
by decrease of its affinity for calcium without a significant change of the Vmax. The inhibition
induced by both oxidants correlated with the formation of higher molecular weight aggregates
of the Na+/Ca2+-exchanger, and in addition AAPH also caused fragmentation of the exchanger
protein.
In contrast, in cardiac muscle myocytes, hypoxia inhibits the Na+/Ca2+-exchanger and ROS are
required for its rapid reactivation upon reoxygenation [256]. This is consistent with the earlier
demonstration in ventricular myocytes of stimulation of the Na+/Ca2+-exchanger by H2O2 and
superoxide anion [257]. Owing to the different pattern of Na+/Ca2+-exchanger isoforms
expression in brain cells and cardiac myocytes, more experimental studies are needed to reach
solid conclusions regarding the effects of oxidative stress on the activity of this exchanger in
different neuronal types and also in the glial cells of the brain.
6. Space and time fluctuations of cytosolic calcium in the neuronal soma
As indicated previously in this chapter, protein compartmentation within microdomains
allows for a more efficient and rapid functional coupling between influx and efflux calcium
transport systems, and this is particularly relevant for neuronal activity, as neurons have to
deliver fast responses to many repetitive and simultaneous extracellular stimuli coming from
different neighbour cells. Studies on calcium signalling in neurons have played a pioneer role
to demonstrate the outstanding role of subcellular compartmentation in the control of neuronal
activity, see for example [5]. As analyzed in more detail in the section 3 of this chapter more
recently reported experimental data point out that the calcium transport systems of the plasma
membrane more relevant for the control of cytosolic calcium homeostasis in neurons are
associated with lipid rafts sub-microdomains or nanodomains. This is an emerging scenario
that opens new perspectives for the rationalization of the modulation of cytosolic calcium
peaks amplitude and also of the rate of attenuation of calcium local gradients in neurons, as
both parameters are strongly dependent on the spatial proximity between systems controlling
calcium entry and extrusion from the cytosol. For example, the rationalization of the transient
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calcium gradients observed between different regions of the neuronal cytosol can be done on
simple grounds taking into account a polarised or focalized distribution of the major calcium
transport systems of the neuronal plasma membrane. Note that, as indicated before in this
chapter, sustained cytosolic calcium concentrations higher than 0.4 μM are strongly cytotoxic
to neurons, but it is a need for neurons to reach these concentrations in the environment of
cytosolic proteins and enzymes having EC50 values for calcium between 0.4 and 1 μM. Indeed,
some of these proteins play a key role in neuronal plasticity and functional responses critical
for proper brain development and function, like calmodulin, nNOS, GAP-43 and CaMK, to
cite only a few of well-established examples.
The calcium concentration reaches values in the micromolar range upon activation of L-VOCC
and NMDA receptors in small volume elements close to the cytosolic side of their calcium
channel structures [258], see also the Figure 2a. This generates a calcium concentration wave
that diffuses within the cytosolic space, because the protein cytosolic buffering systems are not
fast enough to trap all incoming calcium ions through these calcium channels [259, 260]. Due
to the rapid diffusion of calcium ions in the aqueous space of the cytoplasm, ~300 μm2 s-1, the
calcium entry through the high conductance L-VOCC and NMDA receptors channels will
rapidly raise the calcium concentration to the micromolar range within the associated lipid
rafts nanodomains. As these nanodomains have sizes lower than 200 nm, it can be derived that
in less than 1 microsecond the incoming calcium ions will diffuse within the whole space of
the nanodomain, i.e. in the time scale range characteristic for fast conformational relaxation in
proteins. Thus, this clustering serves to built up a very efficient molecular switch for signal
transduction in calcium signalling pathways within neurons, with a time response as fast as
the rapid conformational relaxations elicited by regulatory direct protein/protein interactions.
However, nanodomains can be seen as multi-port exit molecular devices that can serve to many
uni-port exit molecular devices, through regulatory direct protein/protein interactions.
Therefore, the localized calcium rise within these nanodomains not only serves to guarantee
the maximal possible activation of proteins or enzymes with EC50 values ≥0.4 micromolar, such
as those listed above, but also to elicit rapid integrative cellular responses. We shall next briefly
analyze several integrative responses of relevance for the rapid and fine control of cytosolic
calcium homeostasis in neurons elicited by the localized calcium rise within the nanodomains
associated with lipid rafts.
The association of CaMKII with L-VOCC subunit β2a and with NMDA receptors subunit
NR2B, mentioned in the section 2.1 of this chapter, implies that this protein is present in
neuronal nanodomains associated with lipid rafts. A direct consequence of the steep calcium
concentration gradient generated by calcium entry through L-VOCC and NMDA receptors is
the stronger selective activation of the pool of CaMKII that lies in their vicinity over other
CaMKII pools present in neurons. Thus, this will selectively potentiate phosphorylation of
CaMKII substrates present in lipid rafts associated nanodomains. Regarding the cytosolic
calcium homeostasis in neurons, the more relevant effect is the activation of L-VOCC upon
phosphorylation by CaMKII, as this potentiates the increase of the local gradient of calcium
concentration within these nanodomains, leading to a longer lasting increase of the concen‐
tration of cytosolic calcium with the concomitant increase in neuronal secretory activity and
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excitability (Figure 2b). Indeed, it has been shown that L-VOCC plays a relevant physiological
role in NMDA receptors-independent long-term potentiation [28]. The activation and synaptic
clustering of AMPA receptors upon phosphorylation by CaMKII has been shown to potentiate
NMDA receptors activation in the induction of LTP [53]. Noteworthy, L-VOCC blockers like
nifedipine and nimodipine and AMPA antagonists/inhibitors have been shown to have anti-
epileptic therapeutic effects, pointing out that overstimulation of L-VOCC and/or AMPA
underlies, at least, some types of epileptic seizures.
The high concentration of calcium attained within the nanodomains associated with lipid rafts
allows for a stronger and faster selective stimulation of the pool of nNOS localized therein.
Because of the rapid diffusion coefficient of nitric oxide, these nanodomains can be seen as the
most relevant plasma membrane points for focalized nitric oxide generation in neurons and,
therefore, define the sub-microcompartments of neurons where higher transient concentra‐
tions of nitric oxide are attained upon nNOS stimulation. This fact and the vicinal location of
nNOS and NMDA receptors within these nanodomains, i.e. separated by a distance lower than
40 nm [117], makes of NMDA receptors a major cellular target for the chemical reactivity of
released nitric oxide. As the calcium currents through NMDA receptors are inhibited by
exposure of these receptors to nitric oxide, see the section 5.1 of this chapter, the co-localization
of nNOS and NMDA receptors within these nanodomains serves to potentiate a feedback
retroinhibition mechanism for the attenuation of excessive NMDA receptors activity which
would lead to neuronal excitotoxicity [117], i.e. these nanodomains can be also seen as a
molecular microchip-like structure designed for neuronal protection against the harmful
consequences of overstimulation by L-glutamate (Figure 2c). On these grounds, the reported
stimulation of L-VOCC by nitric oxide, see the section 5.1 of this chapter, can be rationalized
as a molecular compensatory mechanism for the fine tuning of NMDA receptor activity, as it
will lead to an increase of L-glutamate secretion near these nanodomains and this should avoid
excessive depression of NMDA receptor activity in the neuron.
The latter point already highlights a major role of the nanodomains associated with lipid rafts
in the intimate cross-talk between calcium and nitric oxide signalling for the normal physio‐
logical activity of neurons, but also points out that excessive calcium entry through L-VOCC
or NMDA receptors should rapidly lead to unusually large peaks of nitric oxide generation in
these nanodomains. As indicated above in this chapter, it is well established now that the
sustained rise of intracellular calcium and/or nitric oxide can induce neuronal death and are
common features in brain degeneration. Many experimental evidences accumulated up to date
reveal that in some cases the induction of oxidative stress in brain neurodegeneration takes
place before a sustained cytosolic calcium homeostasis deregulation can be observed. For
example, in the case of inflammation of a brain area induced either by a traumatic shock injury
or cerebral stroke the neurons are exposed to a ROS/RNS overshot largely generated by vicinal
glial and vascular endothelial cells. The major sources for the overshot of ROS/RNS observed
in this inflammation episode are the increase of iNOS expression, which produces a nitric oxide
overshot, and activation of plasma membrane NADPH oxidases, which produces a superoxide
anion overshot. Therefore, within the brain area affected by inflammation neurons suffer a
long-lasting exposure to an extracellular microenvironment where the simultaneous presence
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of high nitric oxide and superoxide anion concentrations generate significant amounts of
peroxynitrite, see e.g. [162,169]. In this oxidative scenario, the calcium-entry transport systems
more relevant for the control of neuronal cytosolic calcium homeostasis associated with lipid
rafts nanodomains, NMDA and AMPA receptors and L-VOCC, are strongly activated by
peroxynitrite, see the section 5.1 of this chapter. This produces a large peak of calcium
concentration within these nanodomains, large enough to elicit a large increase of cytosolic
calcium and a strong stimulation of nNOS, leading to an intracellular burst of nitric oxide, and
stimulation of the neuronal metabolic activity and associated intracellular superoxide anion
Figure 2. Functional implications of the association of calcium transport systems and ROS/RNS-sources in the neuro‐
nal plasma membrane. (a) Generation of transients of micromolar calcium concentrations within nano- or sub-micro‐
volume elements. The size attained by these volume elements is strongly dependent on the intensity of the total
calcium inward current through the calcium transport systems clusters within lipid rafts-associated nanodomains and
on the cytosolic calcium buffering capacity (see the text). (b) Faster and long-lasting potentiation of NMDA receptors
(NMDAr). Calcium entry through L-VOCC triggers the activation of associated CaMKII, which elicits (i) a feedback acti‐
vation of L-VOCC potentiating calcium entry and (ii) a recruitment of activated AMPA receptors (AMPAr). (c) Potentia‐
tion of NO -mediated protection against L-glutamate excitotoxicity. The co-localization of nNOS allows to reach
higher NO concentrations near NMDA receptors and L-VOCC potentiating its effects on these calcium transport sys‐
tems. (d) Peroxynitrite-induced sustained cytosolic calcium deregulation. A dramatic consequence of an unbalanced
overstimulation of calcium transport systems that raise the cytosolic calcium concentration. Other abbreviations used
in this figure: PM, plasma membrane; Mit, mitochondria; ER, endoplasmic reticulum; ONOO-, peroxynitrite;, protein
phosphorylation; ⊕, stimulation; ⋈ and X, inhibition or blockade.
Neurochemistry84
generation, oxidative conditions that generate intracellular peroxynitrite. In turn, these
intracellular oxidative conditions produce the release of calcium from endoplasmic reticulum
and mitochondria (see the section 5.2 of this chapter), contributing to a further and more
widespread rise of cytosolic calcium concentration, and partial inactivation of the extrusion
systems of the neuronal plasma membrane, PMCA and NCX (see the section 5.3 of this
chapter). These latter effects lead to impairment of the ability of neurons to restore the low
cytosolic calcium concentration needed for their normal function, and as a result lead to a long-
lasting rise of cytosolic calcium concentration which can eventually reach the level that elicits
a rapid necrotic death. Thus, impairment of the calcium transport systems of nanodomains
associated with lipid rafts results in generation of an intracellular ROS/RNS oxidative stress
that amplifies the oxidative stress suffered by exposure of neurons to a combined ROS/RNS
extracellular oxidative stress (Figure 2d). Indeed, many experimental studies have shown that
pharmacological compounds that inhibit the calcium currents through NMDA and AMPA
receptors and L-VOCC behave as protection agents against neuronal death in inflammatory
brain insults.
Experimental evidences have pointed out that there is a large mesh/network of lipid rafts-
associated nanodomains in the plasma membrane of the soma of primary cultures of cerebellar
granule neurons, where they are particularly enriched in neuron/neuron contact areas [130],
and microscopy images have also shown a distribution map that closely overlap with the
distribution map of flavoproteins bound to the plasma membrane [130,261], consistent with
the association of the flavoproteins nNOS and cytochrome b5 reductase with these nanodo‐
mains. Because of the strong impairment of the activity of calcium transport systems present
in these nanodomains by many ROS/RNS that can be generated in the neuronal cytoplasm
under a variety of cellular stress conditions, it should be expected that even exposure of
neurons to a relatively mild oxidative stress should elicit a partial failure of the control of
calcium homeostasis within these neurons. Owing to the large intracellular space occupied by
nuclei in these neurons, partial failure in the control of cytosolic calcium homeostasis should
elicit significant fluctuations of the cytosolic calcium concentration even in the absence of
neuronal stimulation. The occurrence of basal endogenous oscillations of the cytosolic calcium
concentration have been reported in in vitro cultures of different types of neurons, see for
example [186,262-264]. We have recorded synchronized fluctuations of the cytosolic calcium
concentration in primary cultures of rat cerebellar granule neurons, of an average amplitude
of ±0.15 units of the ratio 340/380 in cells loaded with fura-2, by simply increasing the intensity
of UV-irradiation in the epifluorescence microscope [Marques-da-Silva D and Gutierrez-
Merino C, unpublished results], conditions that promote an increase of H2O2 production by
cellular flavoproteins. The implication of nanodomains associated with lipid rafts in the
generation of these cytosolic calcium fluctuations is unravelled by their attenuation by specific
inhibitors or blockers of the calcium transport systems associated with these nanodomains. In
this particular case the calcium entry through L-VOCC plays a major role in the modulation
of the amplitude of the UV-induced fluctuations of cytosolic calcium concentrations. However,
it is to be noted that other calcium transport systems associated with lipid rafts can also play
a major role under different experimental conditions, as it has been shown that NCX interac‐
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tions with another proteins bound to lipid rafts can elicit cytosolic calcium oscillations in
oocytes [265].
6.1. The role and relevance of cytosolic calcium buffering systems
The activation of a channel with a typical conductance of 2.6 pS, like that of some calcium
channels, can generate a calcium diffusion sub-microcompartment where the calcium con‐
centration is higher than 1 μM, but the effective dimensions of this volume element is largely
dependent upon the calcium buffering capacity of the microenvironment, increasing from only
several nanometers with a millimolar calcium buffering capacity up to 82 nm in presence of a
calcium buffering capacity equal to that afforded by 0.1 mM fura-2 [258]. The higher the
conductance of the calcium channel, the higher the effective dimension of this sub-microcom‐
partment. Using the equations derived in [260], for channels with unitary calcium conductan‐
ces in the range of 20 to 40 pS, i.e. that of L-VOCC and NMDA receptors (section 2.1 of this
chapter), effective dimensions of a sub-microcompartment with calcium concentrations higher
than 1 μM can extend to several hundreds of nanometers taking into account that only
micromolar concentrations of calcium buffering systems are present in the neuronal cytosol
(Figure 2a). Because of the high neurotoxicity of cytosolic calcium concentrations in the
micromolar range, a decrease of the calcium buffering capacity of the cytosol shall increase the
propensity for rapid degeneration of neurons.
On these grounds, it can be easily understood that the role of the cytosolic calcium buffering
in neurons has attracted considerable interest, not only because of the abundance of calcium-
binding proteins in the nervous system but also because of the specificity of their regional
distribution in the brain. It is also relevant herein to note that an altered expression of the major
calcium-binding proteins has been noticed in damaged brain regions of patients suffering from
acute insults, such as stroke or epileptic seizures, and from chronic human neurodegenerative
disorders which develop with an enhanced oxidative stress in the brain, such as Alzheimer's,
Huntington's, Parkinson's and Pick's diseases [266]. Several of the major calcium-buffering
proteins present in the brain have been reported to show altered expression levels in degen‐
erating brain regions, namely, parvalbumin, calbindin-D28K and S100, all of them members
of the EF-hand calcium binding proteins like the calcium-binding protein calmodulin ubiqui‐
tously expressed in all mammalian cells. Furthermore, it has been proposed that the lack of
calcium buffering proteins parvalbumin and calbindin-D28K may be considered one of the
factors that render human motor neurons particularly vulnerable to calcium toxicity following
glutamate receptor activation in amyotrophic lateral sclerosis [267]. Consistently, it has been
reported that parvalbumin overexpression delays disease onset in a transgenic model of
familial amyotrophic lateral sclerosis [268], a devastating and oxidative stress-mediated
neurodegenerative disease of the brain.
Because of the high relevance of calmodulin as a multifunctional modulator of cellular calcium
homeostasis and also of cellular calcium signalling pathways [4-6], this is the calcium binding
protein of the EF-hand family whose functional and structural alterations by ROS have been
more extensively studied [269]. In this regard, calmodulin-dependent proteins particularly
relevant for the control of calcium homeostasis in neurons are the calcium transport systems
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PMCA and IP3-receptors, see above. In addition, calmodulin modulates signalling pathways
controlling neuronal activity and synaptic plasticity like the protein phosphatase calcineurin,
CaMK and IQ motif-containing proteins, such as myosins, Ras exchange proteins and GAP-43
among others [141,270,271]. Noteworthy, the activity of calcineurin has been reported to be
decreased in sporadic and familial amyotrophic lateral sclerosis [272]. Calmodulin has been
shown to become more oxidized in aged animals [269], pointing out that the physiological
oxidative stress developed in the tissues is enough to lead to a sustained chemical modification
of this protein. In vitro calmodulin suffers chemical oxidative modifications upon exposure to
either H2O2 or peroxynitrite, for a review on this topic see [269]. Two vicinal methionine
residues close to the carboxyl-terminus of calmodulin, Met-144 and Met145, are oxidized to
methionine sulfoxide in aged tissues and also by H2O2 and more efficiently by peroxynitrite.
Calmodulin oxidation leads to inhibition of the target proteins by non-productive association
and stabilization of their inactive state. This has been experimentally demonstrated for the
PMCA [273-275]. The oxidation of these methionines is reversible in vivo, as methionine
sulfoxide reductases can efficiently reduce them back to methionine, restoring normal
calmodulin function [269]. The fact that in aged tissues this oxidation is not fully reverted
indicates a functional loss of this recycling process during aging. Thus, oxidation of calmodulin
leads to a transient inactivation of neuronal PMCA. On these grounds, the fact that high levels
of expression of calcium binding proteins are observed in neurons expressing nNOS [276-279]
can be seen as a protective mechanism to attenuate long-lasting calcium transients in these
neurons, which could eventually elicit cell death through calpains activation.
The widespread expression of calmodulin in the brain, its high level of expression in neurons
relative to other cell types and its pleiotropic cellular functions confer a high relevance to the
oxidative modifications of this protein by ROS/RNS. Regarding specifically the calcium
transport systems associated with lipid rafts nanodomains, a loss of functional calmodulin
leads to a marked decrease of the CaMK activity and this, in turn, leads to a decrease of the
activity of the calcium entry systems L-VOCC and AMPA and NMDA receptors. As a result,
the calcium concentration within these sub-microcompartments will be lowered up to levels
closer to those found in the overall cytosol. Although the PMCA will also be inhibited, this
inhibition by itself cannot compensate a large decrease of the inward calcium currents for two
major reasons: (i) in neurons PMCA is also stimulated by phosphatidylserine and in these cells
calmodulin stimulation is weak relative to other cell types [280], and (ii) the higher potency
for transport across the open calcium channels of L-VOCC and NMDA receptors with respect
to that of PMCA. Therefore, these nanodomains can eventually enter in a latent state regarding
calcium and nitric oxide signalling in neurons. A simple and rational hypothesis merges from
this conclusion, namely, that this could be a molecular mechanism underlying the observed
loss of neuronal threshold excitability in aging and brain neurodegeneration. Owing to its
putative relevance for the search of new therapeutic drugs and treatments for slow-developing
neurodegenerative processes, this hypothesis deserve to be experimentally assessed in future
studies.




The organization of the major calcium transport systems controlling the cytosolic calcium
homeostasis within nanodomains of the neuronal plasma membrane associated with lipid rafts
is opening new perspectives for regulation and deregulation of calcium signalling in neurons.
In addition to the relevance of this fact for the efficient neuronal function in brain associative
structures, like the concerted activity in neuronal circuits and LTP, the co-localization of ROS/
RNS enzyme sources within these nanodomains is of particular relevance for neurodegener‐
ative insults and diseases. The basic reason for this conclusion is that the calcium transport
systems playing a major role in cytosolic calcium homeostasis and calcium-mediated neuronal
activity are highly sensitive to modulation by ROS/RNS, and that oxidative stress is a common
feature observed during the development of brain damage elicited in the most frequent brain
insults and neurodegenerative diseases of high prevalence in humans. Yet, the actual knowl‐
edge of the molecular structure and plasticity of these nanodomains is still very limited, both
in terms of their molecular composition in different types of neurons and of the factors
controlling its formation and structural organization. Moreover, the molecular mechanisms
leading to deregulation of the ROS/RNS enzyme sources associated with these nanodomains
remain to be established, as well as the structural changes induced in these nanodomains by
exposure to the different ROS/RNS that are generated in neurodegenerative insults and
diseases. Because of the central role of cytosolic calcium in the control of neuronal activity,
plasticity and survival it can be foreseen that these nanodomains will become a relevant
pharmacological target in the search for alternate and novel therapies aiming to prevent or
slowdown neurodegenerative processes in the brain.
Abbreviations used in the text
AAPH, 2,2'- azobis (2-amidinopropane) dihydrochloride; AMPA, α-amino-3-hydroxy-5-
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isoform II; Cb5R, cytochrome b5 reductase; cGMP, 3’,5’-cyclic guanosine monophosphate; CNS,
central nervous system; COX, cyclooxygenase; EDTA, ethylenediamine-tetraacetic acid; FRET,
fluorescence resonance energy transfer; LTP, long-term post-synaptic potentiation; NCX,
sodium-calcium exchanger; NMDA, N-methyl-D-aspartate; nNOS, neuronal nitric oxide
synthase; NOX, ROS-generating NADPH oxidases; PKA, protein kinase A; PKC, protein
kinase C; PMCA, plasma membrane calcium pump; ROS, reactive oxygen species; RNS,
reactive nitrogen species; SIN-1, 3-morpholinosydnonimine; SOCE, store-operated calcium
entry; UV, ultraviolet; VOCC, voltage-operated caclium channels (L-VOCC, L-type VOCC; N-
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